31 Mar 2019
Assets1,475.40
Total Income886.87
EBITDA248.16
Profit After Tax195.59
NET Worth88.13
Reserves and Surplus86.17
Total Borrowing0.02
At a glance
Updated 2026-08-23Glenmark Life Sciences is a Mainboard IPO with an issue size of ₹1,513.60 crore, proposed for listing on BSE, NSE. The offer opens on 27th Jul 2021 and closes on 29th Jul 2021. The issue structure includes a fresh issue of ₹1,060.00 crore and an offer-for-sale component of ₹453.60 crore. The current listing schedule points to 6th Aug 2021.
Issue details
Listing atBSE, NSE
Issue typeBook Build Issue
Issue size₹1,513.60 Cr
Fresh issue₹1,060.00 Cr
Offer for sale₹453.60 Cr
Face value₹2
Price band₹695.00–₹720.00
Allotment3rd Aug 2021
Listing6th Aug 2021
Grey market
GMP page ↗Latest GMP₹82.00
GMP / upper price11.39%
Est. listing₹802.00
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens27th Jul 2021
Closes29th Jul 2021
Allotment3rd Aug 2021
Refund4th Aug 2021
Demat5th Aug 2021
Listing6th Aug 2021
Subscription demand
Full bidding ↗NO DATAWaiting for a verified live exchange update.
Company
Use of proceeds
| Object | Amount |
|---|---|
| Payment of outstanding purchase consideration to the Promoter for thespin-off of the API business from the Promoter into our Companypursuant to the Business Purchase Agreementdated October 9, 2018 | ₹800.00 Cr |
| Funding the capital expenditure requirements | ₹152.76 Cr |
| General corporate purposes | ₹57.68 Cr |
Financials
Full financials ↗31 Mar 2020
Assets1,725.60
Total Income1,549.30
EBITDA483.95
Profit After Tax313.10
NET Worth401.69
Reserves and Surplus399.73
Total Borrowing0.02
31 Mar 2021
Assets1,997.08
Total Income1,885.98
EBITDA591.89
Profit After Tax351.58
NET Worth752.75
Reserves and Surplus750.79
Total Borrowing0.00
Trend chart₹ crore
KPIs
| KPI | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Lead Managers fees | 40.84 |
| 2 | Commission/processing fee for SCSBs, Sponsor Bank and Bankers to the Offer. Brokerage, underwriting commission and selling commission and bidding charges for Members of the Syndicate, Registered Brokers, RTAs and CDPs | 9.24 |
| 3 | Fees payable to the Registrar to the Offer | 0.42 |
| 4 | Fees payable to the other advisors to the Offer | 2.38 |
| 5 | Listing fees, SEBI filing fees, BSE and NSE processing fees, book building software fees and other regulatory expenses | 5.55 |
| 6 | Printing and stationery | 1.91 |
| 7 | Advertising and marketing expenses | 5.1 |
| 8 | Fee payable to legal counsels | 4.03 |
| 9 | Miscellaneous | 2.37 |
Issue expenses
| Expense | Amount |
|---|---|
| Lead Managers fees | ₹40.84 Cr |
| Commission/processing fee for SCSBs, Sponsor Bank and Bankers to the Offer. Brokerage, underwriting commission and selling commission and bidding charges for Members of the Syndicate, Registered Brokers, RTAs and CDPs | ₹9.24 Cr |
| Fees payable to the Registrar to the Offer | ₹0.42 Cr |
| Fees payable to the other advisors to the Offer | ₹2.38 Cr |
| Listing fees, SEBI filing fees, BSE and NSE processing fees, book building software fees and other regulatory expenses | ₹5.55 Cr |
| Printing and stationery | ₹1.91 Cr |
| Advertising and marketing expenses | ₹5.10 Cr |
| Fee payable to legal counsels | ₹4.03 Cr |
| Miscellaneous | ₹2.37 Cr |
Registrar & lead managers
Registrar
Kfin Technologies Ltd.Lead managers
- Kotak Mahindra Capital Co.Ltd.
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-08-23.